Patrick Dixon
Psychiatric/Mental Health · Anoka, MNNPI 1417308313
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,622 of the $2,574 with a category attached, or 63.0%. 24 manufacturers reported payments, led by Relievant Medsystems, Inc. at 47.9% of the total. Reporting peaked in 2022 at $1,398 and has fallen 76.1% since, to $334 in 2025. Among psychiatric/mental health clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $46.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$1K
- Livanova USA, Inc.$292
- Teva Pharmaceuticals USA, Inc.$285
- Tempus AI, Inc$149
- Vanda Pharmaceuticals Inc.$93
- Abbott$78
- plus $445 from 18 others
What the payments were for
- Travel & lodging$95237%
- Food & beverage$1,62263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 6 | $1,232 |
| Livanova USA, Inc. | 2 | $292 |
| Teva Pharmaceuticals USA, Inc. | 7 | $285 |
| Tempus AI, Inc | 4 | $149 |
| Vanda Pharmaceuticals Inc. | 5 | $93 |
| Abbott | 4 | $78 |
| Nevro Corp. | 3 | $67 |
| Neuronetics, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| AbbVie(2 entities) | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Lundbeck LLC | 2 | $31 |
| Amgen | 2 | $26 |
| Almatica Pharma LLC | 2 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| USWM, LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Corium, LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,136
- VNS Therapy Symmetry Model 8103 Generator$292
- UZEDY$117
- Austedo XR$107
How this compares
$2,574 in reported general payments places this provider in the 95th percentile of 407 psychiatric/mental health providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 39 | $37,471 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 110 | $30,665 |
| VraylarCariprazine Hcl | 11 | $16,162 |
| SavellaMilnacipran Hcl | 12 | $5,266 |
| SymproicNaldemedine Tosylate | 12 | $4,999 |
| Buprenorphine Hcl | 52 | $2,548 |
| Pregabalin | 53 | $781 |
| Gabapentin | 44 | $759 |
| Aripiprazole | 17 | $608 |
| Naltrexone Hcl | 12 | $543 |
| Tizanidine Hcl | 62 | $442 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $427 |
| Clozapine | 29 | $415 |
| Bupropion XlBupropion Hcl | 17 | $280 |
| Clonidine Hcl | 21 | $200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $32 | $37,47139 claims |
| AbbVieVraylar, Savella | $35 | $21,42823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 407 psychiatric/mental health providers in Minnesota.
Other psychiatric/mental health in Anoka
- Jill ScottAnoka$5K
- Jacqualine GervaisMoorhead$29K
- Naomi KoenigSandstone$8K
- Dana BageonWayzata$7K
- Holly WillisMinneapolis$5K
- Gerard BalanMinneapolis$5K
- Hilary BreedonShakopee$3K
- Tina AlexanderEdina$3K
- Twilla OskeyBaxter$3K
- Sara OckerCambridge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.